50bio.Comsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-03-14
Share capital
5 000,00 PLN
Registered address
ul. Złota 59, 00-120 Warszawa, Poland
Website
50bio.comWebsite active
Email
Email address current

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 857.93kMedianUSD 72.15kAverageUSD 3.22m
Net profit
This companyUSD 52.02kMedianUSD 87.69AverageUSD 112.20k
Operating costs
This companyUSD 770.17kMedianUSD 75.02kAverageUSD 3.02m
Assets
This companyUSD 333.70kMedianUSD 121.49kAverageUSD 3.89m

Bank accounts

Registered as a VAT taxpayer on 2018-04-09. Active

  • mBank
    94 1140 2004 0000 3502 7753 0170
  • mBank
    53 1140 2004 0000 3403 0015 0872
  • mBank
    19 1140 2004 0000 3012 0646 7494

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
—

Tenders

5 tenders recorded as contractor: 1 national ($53,581) and 4 EU ($1,604,853).

SubjectAmount
Usługa monitorowania badania klinicznego oraz wsparcia merytorycznego w związku z realizacją projektu pn. „Wpływ sakubitrylu/walsartanu w porównaniu z ramiprylem na przebudowę i funkcję lewej komory u pacjentów z niewydolnością serca o etiologii niedokrwiennej i pośrednią frakcją wyrzutową” akronim CRACOVIA-HF (2019/ABM/1/00049)
$141.8K
Kompleksowy nadzór nad realizacją badania klinicznego
$296.5K
20.2024 Monitorowanie eksperymentu medycznego AIDA wraz z dostawą i obsługą systemu eCRF dla Katedry i Kliniki Hematologii, Nowotworów Krwi i Transplantacji Szpiku Uniwersytetu Medycznego we Wrocławiu
$1.0M

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Bartosz Arkady Maciejewski — Management Board Member
Konrad Henryk Maciejewski — Management Board Member

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Bartosz Arkady Maciejewski (29)
45$607.7845%
Konrad Henryk Maciejewski (55)
55$742.8455%

Konrad Henryk Maciejewski and Bartosz Arkady Maciejewski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person
Bartosz Arkady Maciejewski (29)
Konrad Henryk Maciejewski (55)

Competitors

Name
Satagrosp. z o.o.
Instytut Materiałów Budowlanych i Technologii Betonusp. z o.o.
DR Koziejsp. z o.o. + limited partnership
Florabosp. z o.o.
Retailicsp. z o.o.
EkoparkS.A.
CTI Clinical Trial And Consulting Services Polandsp. z o.o.
Unia Producentów I Pracodawców Przemysłu Biogazowego I BiometanowegoEmployers' association
Lemontechsp. z o.o.
Nevomo Polandsp. z o.o.

Change history

DateEvent
2019-12-19PKD change
2018-03-14Entered in the register

FAQ

Last updated: 2026-09-14